Israel is one of the world's most experienced medical cannabis markets — legal since 2011, with ~120,000 licensed patients and ~60 active manufacturers. IMFA-issued GMP certificates are bilaterally recognised by the EU, UK, Australia, and Canada, making Israel a significant global exporter. The IMFA export authorization process is well-established and widely understood by importing country authorities.
Ask the Expert about Israel